Rare diseases
Investigational molecules
Locations
Back to Italy2 835 clinical trials in San Donato Milanese, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
ItalyRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
ItalyRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
ItalyA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
ItalyA Phase 3 Study of Once‑Monthly PF‑08653944 vs Placebo for Weight Loss in Adults with Overweight or Obesity
ItalyStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
ItalyEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
ItalyPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
ItalyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
ItalyA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
ItalyLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
ItalyPhase 2 Study of Safety and Efficacy of PF-08634404 Alone or with Drug Combination in Adults with Early-Stage or Locally Advanced Non-Small Cell Lung Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Leading studies focusing on inflammatory bowel diseases, including investigations of novel treatments for Crohn's Disease and Ulcerative Colitis. Research encompasses both established and experimental therapies aimed at inducing clinical remission.
Multiple trials evaluating innovative therapeutic approaches for gastrointestinal conditions.
Comprehensive research into heart conditions, with particular emphasis on hypertrophic cardiomyopathy and heart failure. Studies evaluate new medications and surgical interventions.
Innovative approaches in treating various cardiac conditions using precision medicine techniques.
Groundbreaking studies in hereditary angioedema and chronic urticaria, investigating both preventive treatments and acute attack management strategies.
Advanced therapeutic options being developed for rare immunological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
